These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24441398)

  • 1. Multifunctional aptamer-miRNA conjugates for targeted cancer therapy.
    Esposito CL; Cerchia L; Catuogno S; De Vita G; Dassie JP; Santamaria G; Swiderski P; Condorelli G; Giangrande PH; de Franciscis V
    Mol Ther; 2014 Jun; 22(6):1151-1163. PubMed ID: 24441398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates.
    Catuogno S; Rienzo A; Di Vito A; Esposito CL; de Franciscis V
    J Control Release; 2015 Jul; 210():147-59. PubMed ID: 25998051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to train your dragon: targeted delivery of microRNA to cancer cells in vivo.
    Kortylewski M; Nechaev S
    Mol Ther; 2014 Jun; 22(6):1070-1071. PubMed ID: 24881764
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting Axl with an high-affinity inhibitory aptamer.
    Cerchia L; Esposito CL; Camorani S; Rienzo A; Stasio L; Insabato L; Affuso A; de Franciscis V
    Mol Ther; 2012 Dec; 20(12):2291-303. PubMed ID: 22910292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells.
    Esposito CL; Nuzzo S; Kumar SA; Rienzo A; Lawrence CL; Pallini R; Shaw L; Alder JE; Ricci-Vitiani L; Catuogno S; de Franciscis V
    J Control Release; 2016 Sep; 238():43-57. PubMed ID: 27448441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer-MiRNA Conjugates for Cancer Cell-Targeted Delivery.
    Esposito CL; Catuogno S; de Franciscis V
    Methods Mol Biol; 2016; 1364():197-208. PubMed ID: 26472452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective.
    Vandghanooni S; Eskandani M; Barar J; Omidi Y
    J Mol Med (Berl); 2018 Sep; 96(9):885-902. PubMed ID: 30056527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression.
    Quirico L; Orso F; Esposito CL; Bertone S; Coppo R; Conti L; Catuogno S; Cavallo F; de Franciscis V; Taverna D
    Int J Biol Sci; 2020; 16(7):1238-1251. PubMed ID: 32174798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA.
    Mackiewicz M; Huppi K; Pitt JJ; Dorsey TH; Ambs S; Caplen NJ
    Breast Cancer Res Treat; 2011 Nov; 130(2):663-79. PubMed ID: 21814748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism.
    El Bezawy R; De Cesare M; Pennati M; Deraco M; Gandellini P; Zuco V; Zaffaroni N
    J Hematol Oncol; 2017 Jan; 10(1):19. PubMed ID: 28100259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Axl and Mer kinases in cancer.
    Verma A; Warner SL; Vankayalapati H; Bearss DJ; Sharma S
    Mol Cancer Ther; 2011 Oct; 10(10):1763-73. PubMed ID: 21933973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-432 functions as a tumor suppressor gene through targeting E2F3 and AXL in lung adenocarcinoma.
    Chen L; Kong G; Zhang C; Dong H; Yang C; Song G; Guo C; Wang L; Yu H
    Oncotarget; 2016 Apr; 7(15):20041-53. PubMed ID: 26942465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint Blockade.
    Boshuizen J; Pencheva N; Krijgsman O; Altimari DD; Castro PG; de Bruijn B; Ligtenberg MA; Gresnigt-Van den Heuvel E; Vredevoogd DW; Song JY; Visser N; Apriamashvili G; Janmaat ML; Plantinga TS; Franken P; Houtkamp M; Lingnau A; Jure-Kunkel M; Peeper DS
    Cancer Res; 2021 Apr; 81(7):1775-1787. PubMed ID: 33531370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer.
    Wang Y; Xia H; Zhuang Z; Miao L; Chen X; Cai H
    Cell Death Dis; 2014 May; 5(5):e1227. PubMed ID: 24832599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target.
    Paccez JD; Vasques GJ; Correa RG; Vasconcellos JF; Duncan K; Gu X; Bhasin M; Libermann TA; Zerbini LF
    Oncogene; 2013 Feb; 32(6):689-98. PubMed ID: 22410775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary study on the effect of nucleolin specific aptamer-miRNA let-7d chimera on Janus kinase-2 expression level and activity in gastric cancer (MKN-45) cells.
    Ramezanpour M; Daei P; Tabarzad M; Khanaki K; Elmi A; Barati M
    Mol Biol Rep; 2019 Feb; 46(1):207-215. PubMed ID: 30415442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axl and Mer Receptor Tyrosine Kinases: Distinct and Nonoverlapping Roles in Inflammation and Cancer?
    Dransfield I; Farnworth S
    Adv Exp Med Biol; 2016; 930():113-32. PubMed ID: 27558819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL.
    Li R; Shi X; Ling F; Wang C; Liu J; Wang W; Li M
    Tumour Biol; 2015 Sep; 36(9):7277-83. PubMed ID: 25895459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of HER3 interferes with antitumor effects of Axl receptor tyrosine kinase inhibitors: suggestion of combination therapy.
    Torka R; Pénzes K; Gusenbauer S; Baumann C; Szabadkai I; Őrfi L; Kéri G; Ullrich A
    Neoplasia; 2014 Apr; 16(4):301-18. PubMed ID: 24862757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor.
    Yokoyama Y; Lew ED; Seelige R; Tindall EA; Walsh C; Fagan PC; Lee JY; Nevarez R; Oh J; Tucker KD; Chen M; Diliberto A; Vaaler H; Smith KM; Albert A; Li G; Bui JD
    Cancer Res; 2019 Apr; 79(8):1996-2008. PubMed ID: 30723115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.